Cabuga, Teselyn G.

HRN: 17-33-14  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/06/2022
CEFUROXIME 1.5GM (VIAL)
09/06/2022
09/13/2022
IV
1.5grams
Q8
Acute Pyelonephritis

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: